While other cancer blood tests have focused on identifying individual tumour-associated mutations, Precede Bio’s liquid ...

With Phase III trial results looming in the second quarter of 2024, Annexon Biosciences aims to transform treatment for ...

The linker connects the cytotoxic payload to the mAb. Its purpose is twofold: (1) affording sufficient stability when ADCs ...

Will SK revamp pharmaceutical and bio-affiliates at upcoming CEO meeting Chey Chang-wons appointment spurs strategic shifts ...

MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced a significant milestone in its research with the publication of a new ...

PrognomiQ collected blood samples across 77 clinical sites in the U.S., and processed plasma samples using their in-house Seer ... For more information, please visit www.seer.bio. About PrognomiQ ...

SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel ...

Biogen has signed a definitive agreement to acquire Human Immunology Biosciences (HI-Bio) in a deal worth $1.8bn.

Biogen will make an upfront payment of $1.15 billion to HI-Bio and the latter’s stockholders will be eligible for payments of ...

The 22nd Biomed Israel Conference brings together Israeli Biotech startups, senior pharma and healthcare executives, and ...

Days after backing out of two Ionis-partnered neuro programs, Biogen has inked a potential $1.8 billion buy of Human ...